Veenat is a brand of anti-cancer medication manufactured by Natco Pharma Ltd., containing the active ingredient Imatinib mesylate. It is primarily used to treat various cancers, including chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs), and other malignancies..
Category | Anti-Neoplastic |
Brand | Natco |
Ingredient | Imatinib |
Prescription Required | Yes |
Strength | 100/400mg |
Package | 10 Tablets |
Veenat 100 mg and 400 mg, which contain the active ingredient Imatinib mesylate, work by specifically targeting and inhibiting a group of enzymes known as tyrosine kinases, particularly the BCR-ABL tyrosine kinase. This enzyme is produced by cancer cells in conditions like chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs) and plays a critical role in driving the uncontrolled growth and multiplication of these malignant cells.
The primary benefit of Veenat 100 mg and 400 mg lies in its targeted approach to treating certain types of cancer, particularly chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). By specifically inhibiting abnormal tyrosine kinases like BCR-ABL, Veenat helps to control the unchecked growth and spread of cancer cells, leading to higher remission rates and improved long-term outcomes. Common Side Effects:
The most common side effects of Veenat 100 and 400 mg are
• Nausea and vomiting
• Diarrhea
• Abdominal pain
• Fatigue or tiredness
• Muscle cramps and joint pain
• Swelling (especially around the eyes, hands, or feet)
• Headache
• Rash or skin irritation
• Weight gain (due to fluid retention)
• Loss of appetite
Other side effects of Veenat 100 and 400 mg can include
• Liver toxicity (elevated liver enzymes or hepatitis)
• Low blood cell counts (anemia, neutropenia, thrombocytopenia)
• Bleeding or bruising easily
• Fluid retention in lungs (pleural effusion) or heart (pericardial effusion)
• Heart problems (such as congestive heart failure)
• Severe skin reactions (e.g., Stevens-Johnson syndrome)
• Pancreatitis
• Hypothyroidism (especially in patients with thyroid removal)
• Vision problems (blurred vision, eye pain)
• Shortness of breath or difficulty breathing
Veenat 100 mg and 400 mg (Imatinib mesylate) should not be taken by individuals who are allergic or hypersensitive to Imatinib or any of its inactive ingredients, as this can lead to serious allergic reactions. It is also not recommended for pregnant women, as it may harm the developing fetus, and should only be used during pregnancy if absolutely necessary and under strict medical supervision.
Veenat 100 mg and 400 mg (Imatinib mesylate) should be taken exactly as prescribed by a healthcare provider, usually once or twice daily, depending on the type and stage of cancer being treated. It is important to take the medication with a full glass of water and with food to help reduce the risk of stomach irritation or nausea.
There are no reviews yet.